Of the 6 autoantigens analysed placental-type alkaline phosphatase (PLAP) autoantibodies demonstrated the greatest specificity for ovarian cancer, however immunoreactivity in stage I patients was not significantly different to healthy or benign controls. This evidence concerns the gene ALPP and ovarian cancer.